8-KAccepted Sep 25, 7:43 PM ET
Crown Reserve Acquisition Corp. I Amends Merger Agreement, Extends Outside Date
Accepted (ET)
7:43 PM
Sep 25, 2026
Filed
Sep 28, 2026
Documents
13
Size
339.8 KB
Summary
Crown Reserve Acquisition Corp. I Amends Merger Agreement, Extends Outside Date
What Happened
- On September 23, 2026, Crown Reserve Acquisition Corp. I (the Company), its wholly owned Merger Sub and Carvix, Inc. entered a Second Amendment to the Business Combination Agreement (originally dated March 30, 2026; previously amended August 26, 2026).
- The Amendment replaces Section 9.01(b) to allow either the Company or Carvix to terminate the agreement if the merger has not closed by the later of (i) February 10, 2027 and (ii) the date required under the Company’s Pre‑Domestication Organizational Documents (the new “Outside Date”). The prior Outside Date was September 30, 2026.
- The Amendment also provides that a party cannot terminate the agreement if that party (or its affiliates) breached the agreement and that breach was the principal cause of the failure to satisfy closing conditions.
Key Details
- Amendment effective date: September 23, 2026. Parties: Crown Reserve Acquisition Corp. I, CRAC Merger Sub Inc., and Carvix, Inc.
- New Outside Date: later of February 10, 2027 and the date required under the Company’s Pre‑Domestication Organizational Documents; prior Outside Date was September 30, 2026.
- The filing indicates a Registration Statement (including proxy statement/prospectus) is expected to be filed with the SEC and shareholders will be solicited to vote on the proposed business combination.
- The filing reiterates customary forward‑looking risk factors (e.g., shareholder approval, redemptions reducing trust cash, listing requirements, regulatory/licensing risks).
Why It Matters
- For investors, the Amendment formally extends the deadline to close the proposed merger with Carvix, giving the parties more time to satisfy conditions and complete the transaction.
- Shareholder approval and a forthcoming proxy/prospectus remain required; the filing warns that redemptions, regulatory or listing issues, or other conditions could still prevent closing.
- The change also protects non‑breaching parties by preventing a terminating party from relying on a missed Outside Date if its own breach caused the delay.
Investors should watch for the Registration Statement/proxy statement when filed (it will contain full transaction terms, timing, and risk details) and any updates on shareholder votes, redemptions, or material changes to the transaction.